These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31308953)

  • 1. A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan.
    Uchida M; Suzuki S; Sugawara H; Suga Y; Kokubun H; Uesawa Y; Nakagawa T; Takase H
    J Pharm Health Care Sci; 2019; 5():14. PubMed ID: 31308953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Nationwide Survey of Community Pharmacist Contributions to Polypharmacy in Opioid-Using and Non-using Cancer Patients in Japan.
    Suzuki S; Uchida M; Suga Y; Sugawara H; Kokubun H; Uesawa Y; Nakagawa T; Takase H
    Biol Pharm Bull; 2019 Jul; 42(7):1164-1171. PubMed ID: 30996146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter prospective observational study on hospital pharmacist interventions to reduce inappropriate medications.
    Suzuki S; Uchida M; Sugawara H; Suga Y; Nakagawa T; Takase H
    Front Pharmacol; 2023; 14():1195732. PubMed ID: 37456737
    [No Abstract]   [Full Text] [Related]  

  • 4. Multicentre prospective observational study on community pharmacist interventions to reduce inappropriate medications.
    Uchida M; Suzuki S; Sugawara H; Suga Y; Nakagawa T; Takase H
    Int J Pharm Pract; 2022 Nov; 30(5):427-433. PubMed ID: 35472143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and prevalence of adverse drug events caused by potentially inappropriate medication in homebound elderly patients: a retrospective study using a nationwide survey in Japan.
    Onda M; Imai H; Takada Y; Fujii S; Shono T; Nanaumi Y
    BMJ Open; 2015 Aug; 5(8):e007581. PubMed ID: 26260347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese Nationwide Comparative Survey of Medication Guidance Provided by Certified and Uncertified Palliative Care Pharmacists.
    Tanaka R; Satoh Y; Suga Y; Nakagawa J; Miyazaki M; Hagiwara R; Uchida M; Takase H
    J Nippon Med Sch; 2023; 90(6):449-459. PubMed ID: 38246616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Economic Effect of Pharmaceutical Interventions by Board-Certified Pharmacists in Palliative Pharmacy for Patients with Cancer Using Medical Narcotics in Japan: A Multicenter, Retrospective Study.
    Kawashiri T; Sugawara H; Makihara K; Ohno R; Miyamoto Y; Hidaka N; Uchida M; Takase H
    J Nippon Med Sch; 2024; 91(1):59-65. PubMed ID: 38462441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist Interventions for Adverse Drug Reactions in Palliative Care: A Multicentre Pilot Study.
    Kose E; Nakagawa S; Niki K; Hashizume J; Kawazoe T; Suzuki N; Uchida M; Takase H
    Pharmazie; 2023 Aug; 78(8):141-149. PubMed ID: 37592417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional study to evaluate patients' medication management with a new model of care: incorporating a pharmacist into a community specialist palliative care telehealth service.
    M Chess-Williams L; M Broadbent A; Hattingh L
    BMC Palliat Care; 2024 Jul; 23(1):172. PubMed ID: 39010021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study.
    Ertuna E; Arun MZ; Ay S; Koçak FÖK; Gökdemir B; İspirli G
    Clin Interv Aging; 2019; 14():587-600. PubMed ID: 30962679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of a pharmacist-led intervention on polypharmacy].
    Ooi K
    Nihon Ronen Igakkai Zasshi; 2019; 56(4):498-503. PubMed ID: 31761856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacist interventions in ambulatory psychogeriatric patients with excessive polypharmacy.
    Stuhec M; Zorjan K
    Sci Rep; 2022 Jul; 12(1):11387. PubMed ID: 35794225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial.
    Martin P; Tamblyn R; Benedetti A; Ahmed S; Tannenbaum C
    JAMA; 2018 Nov; 320(18):1889-1898. PubMed ID: 30422193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan.
    Horii T; Atsuda K
    BMC Res Notes; 2020 Mar; 13(1):183. PubMed ID: 32228686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and risk factors for adverse events in Alzheimer's patients receiving anti-dementia drugs in at-home care.
    Imai H; Hirai T; Kumazawa R; Nakagawa S; Yonezawa A; Matsubara K; Nakao H
    PLoS One; 2020; 15(4):e0231226. PubMed ID: 32251456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the GheOP
    Foubert K; Muylaert P; Mehuys E; Somers A; Petrovic M; Boussery K
    Acta Clin Belg; 2020 Dec; 75(6):388-396. PubMed ID: 31241000
    [No Abstract]   [Full Text] [Related]  

  • 17. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
    Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
    Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist-led intervention on potentially inappropriate prescription in patients with polypharmacy: PHARM-PC clinical trial protocol.
    Martínez-Sotelo J; Pinteño-Blanco M; García-Ramos R; Llobera-Cànaves J; Cadavid-Torres MI
    Farm Hosp; 2021 Jun; 45(4):210-215. PubMed ID: 34218768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial.
    Lenander C; Elfsson B; Danielsson B; Midlöv P; Hasselström J
    Scand J Prim Health Care; 2014 Dec; 32(4):180-6. PubMed ID: 25347723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.
    Tasaka Y; Yasunaga D; Tanaka M; Tanaka A; Asakawa T; Horio I; Miyauchi Y; Araki H
    Int J Clin Pharm; 2016 Apr; 38(2):321-9. PubMed ID: 26744362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.